SULFAMYLON 5% TOPICAL SOLUTION Rx
Generic Name and Formulations:
Mafenide acetate 50g/packet; pwd for reconstitution (5% soln after mixing).
Indications for SULFAMYLON 5% TOPICAL SOLUTION:
Adjunct to control bacterial infection when used under moist dressings over meshed autografts on excised burn wounds.
Adults and Children:
<3months: not recommended. ≥3months: Cover grafted area with one layer of fine mesh gauze. Cut an eight-ply burn dressing to the size of graft, wet with solution using an irrigation syringe and/or tubing until noticeable leaking. Maintain moisture with irrigation tubing (see literature) or wet dressing every 6–8 hours as needed. May leave wound dressings undisturbed for up to 5 days, except when irrigating. Additional soaks may be initiated until graft take is complete. Continue treatment until autograft vascularization and healing is progressing (approx. 5 days). Individual grafting procedure: max 5 days. Withhold therapy for 24–48 hours if acidosis occurs.
G6PD deficiency. Sulfite sensitivity. Asthma. Acute renal failure. Monitor acid-base balance closely (esp. with extensive 2nd degree or partial thickness burns, pulmonary or renal impairment). Pregnancy (Cat.C); (crm: not recommended for women of childbearing potential; unless burn area >20% of total body surface). Nursing mothers: not recommended.
Application-site pain, burning sensation, allergic manifestations (eg, rash, pruritus, facial edema, swelling, erythema; discontinue if occur), tachypnea, hyperventilation, metabolic acidosis; respiratory alkalosis, fatal hemolytic anemia with disseminated intravascular coagulation, fungal colonization; rare: excoriation of new skin, bleeding of skin.
Crm—2oz, 4oz, 16oz
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- Triiodothyronine in the Treatment of Bipolar Depression
- Antidepressants Increase Seizure Risk in Youth and Severely Depressed
- Intranasal Oxytocin Reduces Negative Effects, Improves Cognitive Function in Schizophrenia
- E-Cigarettes Associated With More Harms Than Benefits at Population Level
- Examining Rates of Long-Term Opioid Use in Youth With Psychiatric Disorders
- Suicide-Screening Toolkit Can Help Identify Youths at High Risk for Suicide
- Researchers Identify Novel Potential Biomarkers for Autism
- Agoraphobia: An Evolving Understanding of Definitions and Treatment
- Parental Pressure to Diet Linked With Long-term Harm in Adolescents
- Does Access to Medical Cannabis Reduce Risk for Opioid Abuse?
- Supported Employment vs Transitional Work in Veterans With PTSD
- Comparing Pharmacologic Treatments for Prevention of Rehospitalization in BP
- Preliminary Evidence Suggests Suicidal Thinking Is Self-Reinforcing
- Lower Fluoxetine Efficacy in Elderly Patients With Major Depressive Disorder
- Personal Health Information Found in Recycling